Given that the state of HER2 oncogene amplification has important clinical and therapeutic implications for a condition as prevalent as breast cancer, the purpose of this study was to evaluate the status of HER2 oncogene amplification by IHC and FISH in samples from Colombian patients. Here, ERBB2 is linked to breast carcinoma.